PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Interestingly, ceramide concentrations are not elevated in individuals with “PNPLA3 NAFLD.” The authors attributed the lack of hepatic ceramide in subjects with the PNPLA3 variant to their ability to effectively store fat as triglycerides, rather than letting it be diverted into the sphingolipid pathway.